Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
about
MAP'ing CNS development and cognition: an ERKsome processInherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesThe neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAPSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genesEfficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular SchwannomasSchwannoma of the tongue-A common tumour in a rare location: A case report.Giant appendiceal neurofibroma in von Recklinghausen's disease: A case report and literature review.Inadvertent rupture of iridociliary cyst following transscleral Diode laser.Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasmsNeurofibromatosis.Pulmonary arterial hypertension associated with neurofibromatosis type 1.Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.Solitary plexiform neurofibroma of the stomach: a case report.Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies.Severe dyspnea in a patient with neurofibromatosis type 1.A large intrathoracic meningocele in a patient with neurofibromatosis-1Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform NeurofibromasRas in cancer and developmental diseasesMsh6 protects mature B cells from lymphoma by preserving genomic stability.Carbon dioxide laser treatment of cutaneous neurofibromasPancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advancesAchieving consensus for clinical trials: the REiNS International Collaboration.Conclusions and future directions for the REiNS International Collaboration.The versatility of autologous fat transplantation in correction of facial deformities: a single-center experience.Neurofibromatosis-related tumors: emerging biology and therapies.Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.Don't it make my blue eyes brown: heterochromia and other abnormalities of the irisDiffuse large B cell lymphoma presenting as Horner's syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature.Perioperative management of neurofibromatosis type 1.The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2.Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalitiesPreoperative management of giant retroperitoneal schwannoma: A case report and review of the literatureNeurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutationsComprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.How does the Schwann cell lineage form tumors in NF1?Drosophila melanogaster as a model organism of brain diseases
P2860
Q24621710-3A60B163-BABF-473A-A7DB-6F4ACB4A89C4Q24647838-E08FEBCA-DC4B-44DF-8E8E-C39B8EB4231FQ24650089-B4E7D13D-9DD7-4023-9E60-EDB8FF28B9FAQ29615757-537C0CA5-7F3B-4AF0-A240-C25EE22E815DQ30359059-F4ABE263-97AF-4AC8-B77F-B8D70EAEA7FEQ30363216-92D402D6-9268-4979-861F-4C2BF94166BBQ30429016-C5D0BDF1-BC1C-4F84-8802-F4A50D9A652AQ30454186-558840C1-204F-4A3F-9B83-9FDDF881C400Q30457681-EA4CB42D-59E1-47B8-9ED5-772601C503E0Q30467554-EBC14D9D-4A1C-44EA-A3BA-B84D56BEF6B6Q33161531-54C47038-63CA-4406-AC04-37C4B2A40414Q33561323-3A802963-8E44-4061-A923-9D12AE7B79E1Q33564281-9F5E679D-0626-4FF9-BDD1-936C3325F5E2Q33737662-D7A9E1A0-E103-461E-803B-2973039C1BBCQ33855116-AB8AACF9-49FE-41F3-A4A8-C119389A0C54Q33893980-3A545D24-9AF9-45E0-A6E3-00CDD8015169Q33900906-CAB21EA2-DFD6-4C4B-A4CF-AD3D5DFDAD82Q34202697-069EC5CA-3BAC-4D0E-BA8D-947975EF35D4Q34254602-14DD9D79-16DF-42DD-8B4F-DE0722E81A28Q34498185-C6C18E42-1100-49DA-9FB0-3BF17286B063Q34650411-CB48CF0E-AFDE-4FEB-A60E-0224128C3C78Q35046436-BDD1E8CD-FCF4-45E9-AB8C-44CF641C392EQ35046441-9BD67617-06FE-4464-974D-1BE1E83FCC21Q35188079-A190E305-93FC-480E-9313-2CCB9DBFD2CBQ35218073-4A378D28-9DF9-41A4-82DC-2C8FCD2A7D7CQ35639252-7596A125-AEF6-4CF6-84FD-4BF588AB29C3Q35652582-BB61BD7C-F93F-4890-BBA0-FF44E8D5266AQ35676207-6F1BB222-7A7E-4385-B31D-8EFBAD8B5AD7Q35858350-3F96CA4C-0706-44E7-9A2C-5F767B73A833Q36071038-758960C5-72D0-4B0B-A845-47901FFAF4E1Q36180442-73E2EC98-C78F-4FED-A89A-AB54659DE6DDQ36358065-8F0A644A-2532-45D7-A36C-8ECAF64E9074Q36395077-2CB4C085-AD70-4483-9052-DFB76A7A53F2Q36483721-CF0E9212-4B46-48D0-BAF3-A7AD1EA0C12CQ36689380-FB1CA139-CFCF-4648-86CF-F83FA1B5952AQ36954662-8278409F-C488-46B2-88EC-0C396410558BQ36982106-E9340FD4-397C-4624-A52E-DE03E759C0E1Q37008500-F96FCA3B-0B51-4B67-A120-0F4CF1F451DDQ37120518-C7C158FC-3FC6-4C60-A03B-5B5985D6DEE7Q37139826-0D0268AA-CD5B-45C7-8512-CD22C810B7C7
P2860
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@ast
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@en
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@nl
type
label
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@ast
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@en
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@nl
prefLabel
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@ast
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@en
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
@nl
P1433
P1476
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
@en
P2093
Rosalie E Ferner
P304
P356
10.1016/S1474-4422(07)70075-3
P577
2007-04-01T00:00:00Z